These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31713653)
21. High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia. Shigematsu A; Kobayashi N; Yasui H; Shindo M; Kakinoki Y; Koda K; Iyama S; Kuroda H; Tsutsumi Y; Imamura M; Teshima T Biol Blood Marrow Transplant; 2014 Jun; 20(6):801-5. PubMed ID: 24565990 [TBL] [Abstract][Full Text] [Related]
22. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation. Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G; Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180 [TBL] [Abstract][Full Text] [Related]
23. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission. Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332 [TBL] [Abstract][Full Text] [Related]
24. Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in Taiwan. Lee CH; Lin TC; Yao M; Hsiao LT; Ko BS; Liu CJ; Chen TY Cancer Med; 2023 Dec; 12(24):21761-21769. PubMed ID: 38018321 [TBL] [Abstract][Full Text] [Related]
25. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma. El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414 [TBL] [Abstract][Full Text] [Related]
26. Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability. Patriarca F; Einsele H; Spina F; Bruno B; Isola M; Nozzoli C; Nozza A; Sperotto A; Morabito F; Stuhler G; Festuccia M; Bosi A; Fanin R; Corradini P Biol Blood Marrow Transplant; 2012 Apr; 18(4):617-26. PubMed ID: 21820394 [TBL] [Abstract][Full Text] [Related]
27. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma. Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735 [TBL] [Abstract][Full Text] [Related]
28. Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Shigematsu A; Kako S; Mitsuhashi K; Iwato K; Uchida N; Kanda Y; Fukuda T; Sawa M; Senoo Y; Ogawa H; Miyamura K; Takada S; Nagamura-Inoue T; Morishima Y; Ichinohe T; Atsuta Y; Mizuta S; Tanaka J Int J Hematol; 2017 Jun; 105(6):805-811. PubMed ID: 28197965 [TBL] [Abstract][Full Text] [Related]
29. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265 [TBL] [Abstract][Full Text] [Related]
30. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT). González-Barca E; Boumendil A; Blaise D; Trněný M; Masszi T; Finel H; Michieli MG; Bittenbring JT; Gritti G; Snowden JA; Bishton M; Bruno B; de Villambrosia SG; Janikova A; Leleu X; Anagnostopoulos A; Poiré X; Crysandt M; Özkurt ZN; Vandenberghe E; Itälä-Remes M; Cahn JY; Jantunen E; Schroyens W; Maertens J; Esquirol A; Dreger P; Montoto S; Sureda A Bone Marrow Transplant; 2020 Feb; 55(2):393-399. PubMed ID: 31541205 [TBL] [Abstract][Full Text] [Related]
31. Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission. Nishiwaki S; Sugiura I; Fujisawa S; Hatta Y; Atsuta Y; Doki N; Kurahashi S; Ueda Y; Dobashi N; Maeda T; Matsumura I; Tanaka M; Kako S; Ichinohe T; Fukuda T; Ohtake S; Ishikawa Y; Miyazaki Y; Kiyoi H; Am J Hematol; 2024 May; 99(5):806-815. PubMed ID: 38314662 [TBL] [Abstract][Full Text] [Related]
32. Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC. Tessoulin B; Ceballos P; Chevallier P; Blaise D; Tournilhac O; Gauthier J; Maillard N; Tabrizi R; Choquet S; Carras S; Ifrah N; Guillerm G; Mohty M; Tilly H; Socie G; Cornillon J; Hermine O; Daguindau É; Bachy E; Girault S; Marchand T; Oberic L; Reman O; Leux C; Le Gouill S Bone Marrow Transplant; 2016 Sep; 51(9):1184-90. PubMed ID: 27111043 [TBL] [Abstract][Full Text] [Related]
33. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927 [TBL] [Abstract][Full Text] [Related]
34. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study. Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987 [TBL] [Abstract][Full Text] [Related]
35. Allogeneic stem cell transplantation for diffuse large B cell lymphoma: defining the role of allografts. Uhm J; Kuruvilla J Transfus Apher Sci; 2013 Aug; 49(1):63-71. PubMed ID: 23790650 [TBL] [Abstract][Full Text] [Related]
36. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission. Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654 [TBL] [Abstract][Full Text] [Related]
37. Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party. Bazarbachi A; Boumendil A; Finel H; Mohty M; Castagna L; Peggs KS; Blaise D; Afanasyev B; Diez-Martin JL; Sierra J; Bloor A; Martinez C; Robinson S; Malladi R; El-Cheikh J; Corradini P; Montoto S; Dreger P; Sureda A Br J Haematol; 2018 Apr; 181(1):86-96. PubMed ID: 29468647 [TBL] [Abstract][Full Text] [Related]
38. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation. Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658 [TBL] [Abstract][Full Text] [Related]
39. T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. Mariotti J; Devillier R; Bramanti S; Sarina B; Furst S; Granata A; Faucher C; Harbi S; Morabito L; Chabannon C; Carlo-Stella C; Bouabdallah R; Santoro A; Blaise D; Castagna L Biol Blood Marrow Transplant; 2018 Mar; 24(3):627-632. PubMed ID: 29197681 [TBL] [Abstract][Full Text] [Related]
40. Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML. Zheng CC; Zhu XY; Tang BL; Zhang XH; Zhang L; Geng LQ; Liu HL; Sun ZM Bone Marrow Transplant; 2017 Jan; 52(1):88-94. PubMed ID: 27376453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]